Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene therapy
7
×
life sciences
7
×
national blog main
national top stories
biotech
boston blog main
clinical trials
national
new york blog main
new york top stories
san diego blog main
san francisco blog main
san francisco top stories
biogen
boston top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
drug prices
drug pricing
generic drugs
glaxosmithkline
indiana blog main
indiana top stories
merck
roche
zolgensma
abbvie
What
drug
7
×
bio
roundup
long
patients
data
fda
medical
new
news
pricing
road
therapy
acquisitions
advanced
ago
albert
approval
approved
aren’t
arrival
atrophy
award
biggest
biogen’s
biopharmaceutical
biotech
biotechs
bourla
cancer
ceo
companies
company
considering
convo
crispr
daily
death
decades
dems
Language
unset
unknown
Current search:
drug
×
" life sciences "
×
" gene therapy "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More